Vycor Medical Inc
VYCO· OTC
Released Aug 17, 2020
10-Q filed Aug 17, 2020, 48 days after period end · 0001493152-20-016016
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $244.27K | $411.90K | $301.67K | $307.68K |
| Net Income | -$248.89K | -$185.30K | -$418.58K | -$360.72K |
| EPS Diluted | -$0.01 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.02 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.